{
  "main_header": {
    "sid": 927063,
    "name": "P&G Hygiene",
    "stock_name": "P&G Hygiene",
    "full_name": "Procter & Gamble Hygiene & Health Care Ltd.",
    "name_url": "stocks-analysis/p-g-hygiene",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "11,964.95",
    "chg": 174,
    "chgp": "1.48%",
    "dir": 1,
    "prev_price": "11,790.95",
    "mcapval": "38,839.11 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500459,
    "symbol": "PGHH",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE179A01014",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "12.77 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/p-g-hygiene-927063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "P&G Hygiene Sees Revision in Market Evaluation Amidst Challenging Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pg-hygiene-downgraded-to-sell-by-marketsmojo-amidst-weak-financial-and-technical-trends-3730943",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PGHygiene_mojoScore_3730943.png",
        "date": "2025-11-26 09:46:20",
        "description": "P&G Hygiene's market evaluation has undergone a revision reflecting shifts in its fundamental and technical outlook. The changes come amid subdued financial trends and valuation concerns, impacting investor sentiment in the midcap FMCG sector."
      },
      {
        "title": "Are P&G Hygiene latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-pg-hygiene-latest-results-good-or-bad-3680515",
        "imagepath": "",
        "date": "2025-11-07 19:22:39",
        "description": "P&G Hygiene's latest financial results for Q2 FY26 reflect a complex operational landscape. The company reported a net profit of ₹209.86 crores, showing a slight year-on-year decline of 0.96%, while revenue reached ₹1,148.85 crores, marking a modest year-on-year growth of 1.42%. This revenue growth was primarily driven by seasonal demand, yet it highlights underlying challenges in sustaining momentum in a competitive market.\n\nThe operating margin for the quarter was 24.79%, down from 25.64% in the previous year, indicating pressures from rising costs and competitive dynamics. Similarly, the profit after tax (PAT) margin contracted to 18.27%, down from 20.54% in the prior year, further emphasizing the profitability challenges faced by the company.\n\nDespite these challenges, P&G Hygiene demonstrated strong capital efficiency, with a return on equity (ROE) of 71.14%, reflecting its ability to generate substant..."
      },
      {
        "title": "Procter & Gamble Hygiene Faces Financial Adjustments Amidst Mixed Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-hygiene-health-cares-financial-trend-declines-from-positive-to-flat-amid-liquidity-issues-3678313",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ProcterGambleHy_fintrenddot_3678313.png",
        "date": "2025-11-07 08:00:24",
        "description": "Procter & Gamble Hygiene & Health Care reported a flat performance for the quarter ending September 2025, despite a significant profit after tax growth of 37.19% over six months. However, cash reserves have declined, raising concerns about liquidity, while the stock has underperformed compared to the broader market."
      },
      {
        "title": "How has been the historical performance of P&G Hygiene?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-pg-hygiene-3677195",
        "imagepath": "",
        "date": "2025-11-06 22:57:07",
        "description": "Answer:\nThe historical performance of P&G Hygiene shows a consistent upward trend in net sales and operating profit over the years, with net sales reaching 4,191.57 Cr in June 2024, up from 3,905.21 Cr in June 2023 and 3,792.45 Cr in June 2022. Operating profit also increased to 1,022.69 Cr in June 2024 from 909.21 Cr in June 2023. However, profit after tax saw a slight decline to 675.02 Cr in June 2024 from 678.14 Cr in June 2023. The company's total assets decreased to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023, while total liabilities also fell to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023. Cash flow from operating activities decreased to 470.00 Cr in June 2024 from 825.00 Cr in June 2023, indicating a tightening in cash generation.\n\nBreakdown:\nP&G Hygiene has demonstrated a robust growth trajectory in net sales, which climbed from 3,001.99 Cr in June 2020 to 4,191.57 Cr in June 2..."
      },
      {
        "title": "P&G Hygiene Q2 FY26: Premium Valuations Under Pressure as Growth Stalls",
        "link": "https://www.marketsmojo.com/news/result-analysis/pg-hygiene-q2-fy26-premium-valuations-under-pressure-as-growth-stalls-3677451",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ProcterGambleHy_quaterlyResult_3677451.png",
        "date": "2025-11-06 17:48:22",
        "description": "Procter & Gamble Hygiene & Health Care Ltd. (P&G Hygiene), the Indian arm of the global FMCG giant, reported a net profit of ₹209.86 crores for Q2 FY26 (July-September 2025), marking a modest sequential improvement of 9.27% from Q1 FY26's ₹192.06 crores but virtually flat year-on-year growth of just 0.95% from ₹211.90 crores in Q2 FY25. The muted performance has weighed on investor sentiment, with the stock trading at ₹13,230.10 as of November 6, 2025, down 1.34% on the day and reflecting a concerning 16.81% decline over the past year. With a market capitalisation of ₹43,347 crores, the company's premium valuation multiple of 53x trailing earnings faces increasing scrutiny amid decelerating growth momentum."
      }
    ],
    "total": 407,
    "sid": "927063",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/procter-gamble-hygiene-health-care-927063"
  },
  "announcements": [
    {
      "caption": "Corporate Action-Board approves Dividend",
      "datetime": "30-Jan-2026",
      "details": "Dear Sir We are pleased to inform that the Company has declared interim dividend of Rs. 195 per share (including special dividend of Rs. 25 per share) for the financial year 2025-26.",
      "source": "BSE"
    },
    {
      "caption": "Record Date For Interim Dividend",
      "datetime": "30-Jan-2026",
      "details": "Company has fixed record date as February 5 2026 for the purpose of eligibility of payment of interim dividend declared at the board meeting held on January 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended December 31 2025 And Interim Dividend For Financial Year 2025-26",
      "datetime": "30-Jan-2026",
      "details": "We are pleased to inform you that at a meeting of the Board of Directors of the Company held today (commenced at 12:54 P.M. and ended at 01:57 P.M.) the Unaudited Financial Results for the quarter ended December 31 2025 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended December 31 2025; and b. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended December 31 2025 furnished by Statutory Auditors of the Company. Further we are pleased to inform you that the Board of Directors of the Company at its meeting held today inter alia have declared an Interim Dividend for the Financial Year 2025-26 of Rs. 195 per Equity Share (including a one-time special dividend of Rs. 25 per Equity Share). The dividend shall be paid on or before February 27 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Procter & Gamble Hygiene & Health Care Ltd. has declared <strong>650%</strong> dividend, ex-date: 28 Aug 25",
          "dt": "2025-08-28",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

P&G Hygiene Sees Revision in Market Evaluation Amidst Challenging Performance

2025-11-26 09:46:20

P&G Hygiene's market evaluation has undergone a revision reflecting shifts in its fundamental and technical outlook. The changes come amid subdued financial trends and valuation concerns, impacting investor sentiment in the midcap FMCG sector.

Read More

Are P&G Hygiene latest results good or bad?

2025-11-07 19:22:39

P&G Hygiene's latest financial results for Q2 FY26 reflect a complex operational landscape. The company reported a net profit of ₹209.86 crores, showing a slight year-on-year decline of 0.96%, while revenue reached ₹1,148.85 crores, marking a modest year-on-year growth of 1.42%. This revenue growth was primarily driven by seasonal demand, yet it highlights underlying challenges in sustaining momentum in a competitive market. The operating margin for the quarter was 24.79%, down from 25.64% in the previous year, indicating pressures from rising costs and competitive dynamics. Similarly, the profit after tax (PAT) margin contracted to 18.27%, down from 20.54% in the prior year, further emphasizing the profitability challenges faced by the company. Despite these challenges, P&G Hygiene demonstrated strong capital efficiency, with a return on equity (ROE) of 71.14%, reflecting its ability to generate substant...

Read More

Procter & Gamble Hygiene Faces Financial Adjustments Amidst Mixed Performance Indicators

2025-11-07 08:00:24

Procter & Gamble Hygiene & Health Care reported a flat performance for the quarter ending September 2025, despite a significant profit after tax growth of 37.19% over six months. However, cash reserves have declined, raising concerns about liquidity, while the stock has underperformed compared to the broader market.

Read More

How has been the historical performance of P&G Hygiene?

2025-11-06 22:57:07

Answer: The historical performance of P&G Hygiene shows a consistent upward trend in net sales and operating profit over the years, with net sales reaching 4,191.57 Cr in June 2024, up from 3,905.21 Cr in June 2023 and 3,792.45 Cr in June 2022. Operating profit also increased to 1,022.69 Cr in June 2024 from 909.21 Cr in June 2023. However, profit after tax saw a slight decline to 675.02 Cr in June 2024 from 678.14 Cr in June 2023. The company's total assets decreased to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023, while total liabilities also fell to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023. Cash flow from operating activities decreased to 470.00 Cr in June 2024 from 825.00 Cr in June 2023, indicating a tightening in cash generation. Breakdown: P&G Hygiene has demonstrated a robust growth trajectory in net sales, which climbed from 3,001.99 Cr in June 2020 to 4,191.57 Cr in June 2...

Read More

P&G Hygiene Q2 FY26: Premium Valuations Under Pressure as Growth Stalls

2025-11-06 17:48:22

Procter & Gamble Hygiene & Health Care Ltd. (P&G Hygiene), the Indian arm of the global FMCG giant, reported a net profit of ₹209.86 crores for Q2 FY26 (July-September 2025), marking a modest sequential improvement of 9.27% from Q1 FY26's ₹192.06 crores but virtually flat year-on-year growth of just 0.95% from ₹211.90 crores in Q2 FY25. The muted performance has weighed on investor sentiment, with the stock trading at ₹13,230.10 as of November 6, 2025, down 1.34% on the day and reflecting a concerning 16.81% decline over the past year. With a market capitalisation of ₹43,347 crores, the company's premium valuation multiple of 53x trailing earnings faces increasing scrutiny amid decelerating growth momentum.

Read More

View All News